Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13741-13755
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13741
Table 1 Clinical trial of trastuzumab
PatientsPhaseTreatmentnOS (m)PFS (m)RR
Advanced HER-positive gastric cancer as first line (TOGA)III5-FU + cisplatin or capecitabine + cisplatin29011.15.534.5%
5-FU + cisplatin + trastuzumab or capecitabine + cisplatin + trastuzumab29413.86.747.3%